These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 14581115)

  • 1. Naloxone provokes similar pain facilitation as observed after short-term infusion of remifentanil in humans.
    Koppert W; Angst M; Alsheimer M; Sittl R; Albrecht S; Schüttler J; Schmelz M
    Pain; 2003 Nov; 106(1-2):91-9. PubMed ID: 14581115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential modulation of remifentanil-induced analgesia and postinfusion hyperalgesia by S-ketamine and clonidine in humans.
    Koppert W; Sittl R; Scheuber K; Alsheimer M; Schmelz M; Schüttler J
    Anesthesiology; 2003 Jul; 99(1):152-9. PubMed ID: 12826855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term infusion of the mu-opioid agonist remifentanil in humans causes hyperalgesia during withdrawal.
    Angst MS; Koppert W; Pahl I; Clark DJ; Schmelz M
    Pain; 2003 Nov; 106(1-2):49-57. PubMed ID: 14581110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a high-dose target-controlled naloxone infusion on pain and hyperalgesia in patients following groin hernia repair: study protocol for a randomized controlled trial.
    Pereira MP; Werner MU; Dahl JB
    Trials; 2015 Nov; 16():511. PubMed ID: 26554360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraoperative naloxone reduces remifentanil-induced postoperative hyperalgesia but not pain: a randomized controlled trial.
    Koo CH; Yoon S; Kim BR; Cho YJ; Kim TK; Jeon Y; Seo JH
    Br J Anaesth; 2017 Dec; 119(6):1161-1168. PubMed ID: 29029049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of remifentanil-induced analgesia and postinfusion hyperalgesia by parecoxib in humans.
    Tröster A; Sittl R; Singler B; Schmelz M; Schüttler J; Koppert W
    Anesthesiology; 2006 Nov; 105(5):1016-23. PubMed ID: 17065897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid-independent mechanisms supporting offset analgesia and temporal sharpening of nociceptive information.
    Martucci KT; Eisenach JC; Tong C; Coghill RC
    Pain; 2012 Jun; 153(6):1232-1243. PubMed ID: 22503222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of COX inhibition on experimental pain and hyperalgesia during and after remifentanil infusion in humans.
    Lenz H; Raeder J; Draegni T; Heyerdahl F; Schmelz M; Stubhaug A
    Pain; 2011 Jun; 152(6):1289-1297. PubMed ID: 21396775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The endogenous opioid system is not involved in modulation of opioid-induced hyperalgesia.
    Chu LF; Dairmont J; Zamora AK; Young CA; Angst MS
    J Pain; 2011 Jan; 12(1):108-15. PubMed ID: 20864417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remifentanil tolerance and hyperalgesia: short-term gain, long-term pain?
    Yu EH; Tran DH; Lam SW; Irwin MG
    Anaesthesia; 2016 Nov; 71(11):1347-1362. PubMed ID: 27734470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gradual withdrawal of remifentanil infusion may prevent opioid-induced hyperalgesia.
    Comelon M; Raeder J; Stubhaug A; Nielsen CS; Draegni T; Lenz H
    Br J Anaesth; 2016 Apr; 116(4):524-30. PubMed ID: 26934941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of naloxone on opioid-induced hyperalgesia and tolerance to remifentanil under sevoflurane anesthesia in rats.
    Aguado D; Abreu M; Benito J; Garcia-Fernandez J; Gómez de Segura IA
    Anesthesiology; 2013 May; 118(5):1160-9. PubMed ID: 23407105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of remifentanil-induced analgesia, hyperalgesia, and tolerance by small-dose ketamine in humans.
    Luginbühl M; Gerber A; Schnider TW; Petersen-Felix S; Arendt-Nielsen L; Curatolo M
    Anesth Analg; 2003 Mar; 96(3):726-732. PubMed ID: 12598253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mu-opioid agonist remifentanil attenuates hyperalgesia evoked by blunt and punctuated stimuli with different potency: a pharmacological evaluation of the freeze lesion in humans.
    Lötsch J; Angst MS
    Pain; 2003 Mar; 102(1-2):151-61. PubMed ID: 12620606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydrogen-rich saline prevents remifentanil-induced hyperalgesia and inhibits MnSOD nitration via regulation of NR2B-containing NMDA receptor in rats.
    Zhang L; Shu R; Wang H; Yu Y; Wang C; Yang M; Wang M; Wang G
    Neuroscience; 2014 Nov; 280():171-80. PubMed ID: 25241067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of naloxone-sensitive and -insensitive inhibitory systems in a human pain model.
    Koppert W; Filitz J; Tröster A; Ihmsen H; Angst M; Flor H; Schüttler J; Schmelz M
    J Pain; 2005 Nov; 6(11):757-64. PubMed ID: 16275600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No hyperalgesia following opioid withdrawal after the oripavine derivative etorphine compared to remifentanil and sufentanil.
    Freye E; Levy JV
    Eur J Anaesthesiol; 2010 Feb; 27(2):174-80. PubMed ID: 20077594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation of the GluN1 subunit in dorsal horn neurons by remifentanil: a mechanism for opioid-induced hyperalgesia.
    Zhang C; Li SS; Zhao N; Yu C
    Genet Mol Res; 2015 Mar; 14(1):1846-54. PubMed ID: 25867330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of remifentanil-induced postinfusion hyperalgesia by propofol.
    Singler B; Tröster A; Manering N; Schüttler J; Koppert W
    Anesth Analg; 2007 Jun; 104(6):1397-403, table of contents. PubMed ID: 17513631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous remifentanil produces withdrawal hyperalgesia in volunteers with capsaicin-induced hyperalgesia.
    Hood DD; Curry R; Eisenach JC
    Anesth Analg; 2003 Sep; 97(3):810-815. PubMed ID: 12933407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.